Cafepharma Today

AbbVie earnings: Analyst weighs in on drug pipeline, HHS hearing
Europe to review safety data for Eisai-Biogen Alzheimer's drug
Novartis posts better-than-expected fourth-quarter sales
Vertex’s non-opioid pain drug gets FDA approval in milestone for company and research
*please scroll down for all the latest news*

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

*please scroll down for all the latest news*

Current News

submit a press release

WSJ Online
Thursday, January 22, 2009 - 8:44am
PharmExec
Thursday, January 22, 2009 - 8:41am
PharmExec
Thursday, January 22, 2009 - 8:39am
tags:
Seeking Alpha
Thursday, January 22, 2009 - 8:35am
tags:
Bloomberg
Thursday, January 22, 2009 - 8:33am
Forbes
Wednesday, January 21, 2009 - 9:23pm
tags:
CNBC
Wednesday, January 21, 2009 - 4:30pm
Yahoo/AP
Wednesday, January 21, 2009 - 4:28pm
Yahoo/Zacks.com
Wednesday, January 21, 2009 - 4:27pm
tags:
Fierce Pharma
Wednesday, January 21, 2009 - 10:46am
tags:
Yahoo/AP
Wednesday, January 21, 2009 - 10:44am
Yahoo
Wednesday, January 21, 2009 - 10:43am
tags:
InVivo
Wednesday, January 21, 2009 - 10:42am
Seeking Alpha
Wednesday, January 21, 2009 - 9:37am
Washington Post, DC
Wednesday, January 21, 2009 - 9:35am
WSJ Online
Wednesday, January 21, 2009 - 9:25am

Pages

Latest Jobs

Houston, Texas, 77002
Inizio Engage
Fort Worth, Texas, 76102
Inizio Engage
Charlotte, North Carolina, 28245
Inizio Engage
Newark, New Jersey, 07175
Inizio Engage
Little Rock, Arkansas, 72208
Inizio Engage
Philadelphia, Pennsylvania, 19107
Inizio Engage
Las Vegas, Nevada, 89105
Professional Case Management
Atlanta, Georgia, 30383
Inizio Engage
Annapolis, Maryland, 21401
Jazz Pharmaceuticals

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.